Table 1.

(Abstract 17) Summary of real-world outcomes of patients with melanoma brain metastasis in the German ADOReg skin cancer registry. This Table 1 belongs to Abstract 17

	No melanoma brain metastases N = 500	Any melanoma brain metastases
		At least one melanoma brain metastasis N = 164	Single melanoma brain metastasis N = 46	Two or more melanoma brain metastases N = 106
Survival rate at 24 months, %	58.9%	45.7%	58.7%	40.0%
Median OS in months (95% CI)	32.8 (27.6–39.8)	19.6 (13.7—30.3)	47.2 (16.0—NR)	16.7 (10.4 – 25.1)
Median rwToT in months (95% CI)	6.3 (5.3 – 7.2)	6.0 (4.1 – 6.9)	6.5 (3.1 – 12.5)	5.1 (3–5 7.2)

*12 patients had brain metastasis information at baseline, but the number of lesions was unknown; these patients were excluded from analysis by number of brain lesions